ClinicalTrials.Veeva

Menu

Estimation of Functional Liver Reserve Using Cholinesterases

U

University of Milan

Status

Completed

Conditions

Cirrhosis
Liver Neoplasm
Hepatocellular Carcinoma
Liver Disease

Study type

Observational

Funder types

Other

Identifiers

NCT00883454
CHE-HCC

Details and patient eligibility

About

Estimation of functional liver reserve in patients with hepatocellular carcinoma (HCC) in cirrhosis is of paramount importance to properly select candidates for surgical resection. Together with the value of bilirubin, the presence/absence of ascites and esophageal varices, and the rate of residual liver volume, which are our current parameters to measure functional liver reserve, the investigators sought to investigate the value of preoperative cholinesterases (CHE) in predict postoperative adverse outcome after hepatic resection for HCC.

Enrollment

181 patients

Sex

All

Ages

18 to 90 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Total bilirubin < 2 mg/dl

  2. No ascites

  3. No esophageal varices, or esophageal varices eradicated by endoscopy

  4. Liver volume:

    • residual liver volume > or = 40% if total bilirubin < 1 mg/dl
    • residual liver volume > or = 50% if total bilirubin between 1 and 1.5 mg/dl
    • only limited resection if total bilirubin > 1.5 mg/dl
  5. Portal vein embolization was selected in any case in whom RLV did not fit the previous requirements.

Exclusion criteria

  1. Total bilirubin > 2 mg/dl
  2. Refractory ascites
  3. Esophageal varices

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems